As a son of two musicians, Linus Klausenitzer was faced with music at a very young age.
Before he found his passion in playing the bass when he was 15 years old, he learned to play piano and trumpet. After graduating at a musical secondary school, he studied at the music college in Regensburg and graduated from a study course in popmusic at the conservatory in Hamburg. Having gained experience in bands of several genres, the German bass player found his main place in the genre that he has always loved most: Metal Music.
He started to perform internationally as a band member of Fall of Serenity and his first experimental band Noneuclid.
After recording their masterpiece "Metatheosis" Noneuclid's pioneering spirit led to an appearance in the renowned contemporary music festivals “Dag in de Branding” (Den Haag) and “Dutch Music Days” (Amsterdam), where the band premiered the 25-minute death metal symphony “Black Vortex Cathedral” as soloists along with the world famous "Dutch Metropole Orchestra", in front of a stunned classical audience in the fall of 2008. Far away from earlier collaborations between orchestras and metal bands, which mostly tend to be cheesy and shallow, "Black Vortex Cathedral" became a multidimensional plunge into an emotional abyss whose demands drove all musicians to their limits.
In 2010, the band embarked on their next symphonic collaboration, this time with Linus's father Professor Ulf Klausenitzer’s "Bavarian Chamber Orchestra": "Transition Metal", an encounter between the music of Richard Wagner and Noneuclid. In 2011 Linus Klausenitzer joined the band he is most known for: Obscura.
This Technical Death Metal Band distinguished themselves and their unique brand of music via the tasteful use of virtuosity, vocal effects, fretless bass, philosophical underpinnings and other elements rarely touched on in extreme metal. Linus started extensive touring on multiple world tours with such renowned artists as Children of Bodom, Devin Townsend and Death To All. With Obscura he played headliner tours in Europe, Central/North America (USA, Canada, Mexico) and Asia (Japan, United Arab Emirates, Thailand, Singapore, Indonesia, ...).
In 2014 Linus co-founded the extreme metal band Alkaloid which consists of international high-class musicians, including current and former members of Obscura, Spawn of Possession, Aborted, Dark Fortress, Necrophagist, God Dethroned, Blotted Science and Noneuclid. Alkaloid seamlessly ebb and flow through an arrange of styles and genres, creating an intelligent and fascinating blend of Prog, Death Metal, and Fusion. In 2015 Alkaloid was the first German Death Metal band to ever perform in Egypt.
Less than 6 months later Obscura returned with their most dynamic release to date containing several compositions by Linus Klausenitzer. The aptly-named "Akróasis" is packed to the gills with virtuosic musicianship and compelling themes. After it turned out to be a big success the band started intense touring with their bigest world tour ever. Besides his band activities Linus Klausenitzer is doing studio session work on a regular basis. His characteristic 6/7-string fretless bass sound is the main reason why Linus became a renowned session artist recording bass tracks for different musicians and bands worldwide. For his work on "Akroasis" Obscura he is now nominated for Best Bassist of the Year by Loudwire.
Ex - Bands / Cooperation with:
Fall Of Serenity (Melodic Death Metal), Fallacy (Metal Cover Band), King Schlayer (Top 40 Cover Band), Metropole Orkest, Lisa WHO (German Pop Band), Sky (Rock Cover Band), Rockbrigade (Rock Cover Band), Mecallita (Metallica Cover Band) and others
Always a pleasure to spend time at the humongous Meinl Distribution - Großhandel für Musikinstrumente/Ibanez German… twitter.com/i/web/status/10106…
+++Enblood's new music video "Cast To Exile"+++ I am playing a guest solo with my Ibanez hybrid bass "Ashula" at 3:… twitter.com/i/web/status/10037…
A great feature on my favorite bass website No TrebleIn the interview I talk about song writing, the future of ba… twitter.com/i/web/status/10030…